Myxedema coma epidemiology and demographics

Myxedema coma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myxedema coma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myxedema coma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myxedema coma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myxedema coma epidemiology and demographics
CDC on Myxedema coma epidemiology and demographics
Myxedema coma epidemiology and demographics in the news
Blogs on Myxedema coma epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Myxedema coma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Myxedema coma is the extreme expression of severe hypothyroidism and fortunately is rare, with an incidence rate of 0.022 per 100,000 per year. Myxedema coma is more commonly seen in older age group.

Epidemiology

Incidence

The incidence of myxedema coma is approximately 0.022 per 100,000 per year.

Age

Myxedema coma is more commonly seen in older age group.

Gender

Myxedema coma is more common in females.

Race

Myxedema coma is more common in Whites and Asians than in African-Americans.